Announcements Trials
Browse Landscape

Phase

Phase 2 83Phase 1 25Phase 3 19Phase 1/2 19Phase 4 3Phase 2/3 3Phase NA 1

Status

Completed 7Unknown 6Terminated 3Withdrawn 1Active not recruiting 1

Sponsor Class

INDUSTRY 2OTHER 1

Study Type

Interventional 3

Sponsor

Cancer Type

Thoracic 3Other solid neoplasm 1

Conditions

Carcinoma, Non-Small-Cell Lung 2Thoracic Neoplasms 1Mesothelioma 1Lung Neoplasms 1Lung Diseases 1

Interventions

Saline Solution 6Fentanyl 6Sodium Chloride 5Letrozole 5Dexamethasone 5Pregabalin 4Ketamine 4Goserelin 4Gemcitabine 4Bevacizumab 4Tranexamic Acid 3Photochemotherapy 3Pemetrexed 3Paclitaxel 3Metformin 3Leuprolide 3Docetaxel 3Cyclophosphamide 3Carboplatin 3Capecitabine 3Acetaminophen 3ulipristal acetate 2sodium glycididazole 2nilotinib 2liposomal doxorubicin 2human papillomavirus vaccine, L1 type 16, 18 2flurbiprofen axetil 2fludarabine 2fluciclovine F-18 2epoetin beta 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 4 × Terminated × Pemetrexed × Clear all
NCT05583188 2024-07-19

VIGOR

Galvanize Therapeutics, Inc.

Phase 4 Terminated
5 enrolled
Thoracic

Lung Diseases, Lung Neoplasms, Thoracic Neoplasms

NCT03655821 2022-05-13

IMPROVE-II

Radboud University Medical Center

Phase 4 Terminated
81 enrolled
Other solid neoplasmThoracic

Carcinoma, Non-Small-Cell Lung, Mesothelioma

NCT03460678 2020-03-05

Randomized Comparative Study of Erlotinib and Pemetrexed in the Maintenance Treatment of Advanced Lung Cancer Patients.

Hikma Pharmaceuticals LLC

Phase 4 Terminated
9 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung

Data powered by HemOnc (CC BY 4.0) Colophon âš¡